RGNX
NASDAQ · Biotechnology
Regenxbio Inc
$7.38
-0.33 (-4.28%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+150.4% upside
Low Target
$13.35
Average Target
$18.48
High Target
$24.09
Current Price
$7.38
Current
$7.38
$7.38
Target
$18.48
$18.48
$13.35
$18.48 avg
$24.09
Scenario Analysis
Bear Case
$13.35
80.9%
Low target
Base Case
$18.48
+150.4%
Avg target
Bull Case
$24.09
+226.4%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$16.19
-54.4% from high
52-Week Low
$5.46
+35.3% from low
Target vs 52W High
$18.48
+14.1% vs high
Next Earnings Report
Nov 11, 2026 · After Market Close
3d
until earnings
EPS Est: $-1.26
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |